Internal Medicine: Open Access

Internal Medicine: Open Access
Open Access

ISSN: 2165-8048

+44 1625708989

Citations Report

Citations Report - Internal Medicine: Open Access [435 Articles]

The articles published in Internal Medicine: Open Access have been cited 435 times by eminent researchers all around the world. Following is the list of articles that have cited the articles published in Internal Medicine: Open Access.

Guozhong Z, Wenjun H, Junlan L. Efficacy of Wenxin granules combined with metoprolol in the treatment of ventricular premature beats of right ventricular outflow tract. Modern dist edu Chinese Med 2015;11:61-62.

WeiL, Jie W. Application of diarrhea in fever of AIDS. China J Chinese Mater Med. 2013;38(15):2513-2515.

WeiL, Jiang XX, Wang Jie. The theory of escape from diseases. Chinese J Trad Chinese Med 2013;28(10):2847-2850.

WeiL, Wang Jie,Jiang XX. Progress in Diagnosis and Treatment of Salt-Sensitive Hypertension and Thoughts on Prevention and Treatment of Traditional Chinese Medicine. Chinese J Trad Chinese Med. 2013;28(9):2661-2665.

Xiaochen Y,jiang XX,Yun Z, Yongmei L, Jie W. Effects of Bushen Jiangya Recipe on Adiponectin and Insulin Resistance in Spontaneously Hypertensive Rats. World JInte Trad Chinese Western Med 2013 ;8(11):1107-1110.

Effect of Bushen Jiangya Recipe on Adiponectin and Insulin Resistance in Spontaneously Hypertensive Rats

Jiang XX, Yang X, Jie W, Liu Y, Wamg P. Clinical Practice of Classic Mingfang in Treating Hypertension. China J Chinese Mater Medi 2014; 39(5):929-933.

Tian PP, Li J, Gao J, Li Y. Efficacy and safety of the Shexiang Baoxin Pill for the treatment of coronary artery disease not amenable to revascularisation: study protocol for a randomised, placebo-controlled, double-blinded trial. BMJ open 2018;8(2):018052.

Wang J, Xiong X, Liu W. Chinese patent medicine tongxinluo capsule for hypertension: a systematic review of randomised controlled trials. Evid Based Complement Alternat Med 2014;2014.

Liu Wei, Xiong Xingjiang, Wang Jie. Hypertensive Renal Damage and Progress in Prevention and Treatment of Traditional Chinese Medicine. China J Chinese Mater Med 2014;39(1):14-29.

Xiong X, Yang X, Duan L, Liu W, Zhang Y, Liu Y, et al. Traditional Chinese medicine suppresses left ventricular hypertrophy by targeting extracellular signal-regulated kinases signaling pathway in spontaneously hypertensive rats. Sci Rep 2017; 7:42965.

Xiong Xingjiang, Wang Jie. Application of Jingfang in the treatment of hypertension.J Chinese Mater Med 2013; 38(11):1836-1839.

Liu Wei, Xiong Xingjiang, Wang Jie. Understanding and treatment of traditional Chinese medicine in prehypertension. China J Chinese Mater Med2013;38(14):2416-2420.

Wei L, Xingjiang X, Jie W.Knowledge and treatment of traditional Chinese medicine in pre-hypertension.China J Chinese Mat Med 2013 No.14

Xiong X, Wang P, Li X, Zhang Y. Shenqi pill, a traditional Chinese herbal formula, for the treatment of hypertension: a systematic review. Complement Ther Med 2015 1;23(3):484-93.

Wang J, Xiong X, Liu W. Traditional Chinese medicine syndromes for essential hypertension: a literature analysis of 13,272 patients. Evid Based Complement Alternat Med 2014;2014.

Xiong X, Yang X, Feng B, Liu W, Duan L, Gao A,et al. feng decoction, a traditional Chinese herbal formula, for the treatment of essential hypertension: a systematic review of randomized controlled trials. Evid Based Complement Alternat Med. 2013;2013.

MERCK PP. A Phase II, Open-Label Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-3682+ MK-8408 in Subjects with Chronic HCV Genotype 1, 2, 3, 4, 5 or 6 Infection.

Handayani I, Utami T, Hidayat C, Rahayu ES. Screening of lactic acid bacteria producing uricase and stability assessment in simulated gastrointestinal conditions. Intern Food Res J 2018 ;25(4).

Hafez RM, Rahman ATM, Naguib RM. Uric acid in plants and microorganisms: Biological applications and genetics-A review. J Adv Res. 2017 ;8(5):475-486.

Top